Data honesty
- Data source
- Synthetic. The question, claims, sources, and confidence values are hand-authored to demonstrate the substrate — they are not a real study or a real dataset.
- Snapshot
- Static committed snapshot (src/data/ai-evidence.json). It is not produced by scripts/snapshot-examples.mjs and does not come from any live source.
- Live refresh
- No live refresh — the data is fixed. Only the field's own read-out (the agent-json panel) updates, from the running simulation.
- Not claimed
- The field represents confidence, support, and contradiction as weight, cohesion, and charge. It does NOT verify whether any claim is true, and makes no medical or scientific assertion — the confidence numbers are illustrative inputs, not findings.
Fundamental · invisible fields · ai-evidence
An agent reads the field, not the DOM.
Demo · synthetic data · substrate proofOne question. Each claim and each source is a body in an invisible field. Citations are real relationships — support pulls a claim and its sources together (cohesion), a contradicting claim carries opposite polarity (charge), confidence is the claim's mass, and stale sources decay. The field is invisible; its effect shows in the type.
The panel on the right is the same field read as data. It is driven by
field.query() through an agent-json projection — the structured,
serializable view an agent or tool consumes. No DOM scraping: the evidence graph is a first-class
queryable substrate. Toggle the field off and both the type and the live JSON go quiet.
Does the vaccine reduce transmission in the studied population?
snapshot · Jun 28, 2026- supports
The intervention reduces onward transmission
82% confidence- rct Randomized controlled trial, 41k participants 2025
- cohort Prospective cohort, national registry linkage 2025
- meta Meta-analysis of 22 trials 2024
- contradicts
No measurable effect on transmission at population scale
41% confidence- observational Retrospective observational, single site 2021
- preprint Preprint, not peer-reviewed 2022
- qualifies
Any transmission benefit wanes within six months
58% confidence- cohort Prospective cohort, national registry linkage 2025
- cohort Six-month serological follow-up 2024